Search Results 431-440 of 17464 for Cecum

  1. James R. Cerhan, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    James R. Cerhan, M.D., Ph.D., is a cancer epidemiologist at Mayo Clinic who studies causes and prevention for lymphoma to improve outcomes and survival.

  2. Clinical trials - Oncology (Medical)

    After enrollment, patients will receive one cycle of Induction chemotherapy. Subsequent therapy will be based upon MIBG avidity and ALK status. Patients with ...

  3. Germ cell tumors - Doctors and departments - Mayo Clinic

    Learn about these tumors that form from reproductive cells. Explore treatment options, including surgery, chemotherapy and radiation therapy.

  4. Extracorporeal membrane oxygenation (ECMO) - Doctors & Departments - Mayo Clinic

    Mayo Clinic surgeons are among the world's most experienced. They performed some of the world's first open heart surgeries in children using a heart-lung ...

  5. Clinical trials - Oncology (Medical)

    This randomized, active controlled, multicenter Phase III open-label study is designed to evaluate the efficacy and safety of alectinib compared with ...

  6. MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment - Mayo Clinic

    MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure ...

  7. Clinical trials - Oncology (Medical)

    The purpose of this study is to assess outcomes, satisfaction and aesthetics of two different breast reconstruction techniques (Goldilocks alone, ...

  8. Clinical trials - Oncology (Medical)

    This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients with HER2 expressing ductal carcinoma ...

  9. Clinical trials - Oncology (Medical)

    Scottsdale/Phoenix, Ariz., Rochester, Minn. This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor ...

  10. A Study of Cemiplimab in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy - Mayo Clinic

    The primary objective is to estimate the overall response rate (ORR) for metastatic Basal Cell Carcinoma (BCC) (group 1) and for unresectable locally advanced ...